R. Don Elsey
2021 - Lyra Therapeutics
In 2021, R. Don Elsey earned a total compensation of $829.4K as Former Chief Financial Officer at Lyra Therapeutics, a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $129,860 |
|---|---|
| Option Awards | $339,904 |
| Salary | $350,978 |
| Other | $8,700 |
| Total | $829,442 |
Elsey received $351K in salary, accounting for 42% of the total pay in 2021.
Elsey also received $129.9K in non-equity incentive plan, $339.9K in option awards and $8.7K in other compensation.
Rankings
In 2021, R. Don Elsey's compensation ranked 9,381st out of 12,415 executives tracked by ExecPay. In other words, Elsey earned more than 24.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,381 out of 12,415 | 24th |
Division Manufacturing | 4,161 out of 5,505 | 24th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 556 out of 801 | 31st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 355 out of 522 | 32nd |
Industry Surgical and Medical Instruments and Apparatus | 223 out of 327 | 32nd |
Source: SEC filing on April 27, 2022.
Elsey's colleagues
We found three more compensation records of executives who worked with R. Don Elsey at Lyra Therapeutics in 2021.